 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Ashe K, Liu P. on NEWS: Inducible APP Mice—Cognition Restored in Advanced Amyloidosis?, Regarding the conundrum of cognitive improvement despite lingering Aβ oligomers in the inducible... 1 Mar 2013.
|
|
|
 |
|
|
Ashe K, Liu P, Zahs K. on PAPER: Brouillette J. et al., 2012, Buée, De Strooper and colleagues have presented a novel mouse model in which to study Aβ... 9 Jun 2012.
|
|
|
|
|
|
Ashe K, Zahs K. on PAPER: Golde TE. et al., 2011, In their recent perspective in Neuron, Golde, Schneider, and Koo provide a cogent synthesis of... 9 Feb 2011.
|
|
|
|
|
|
Ashe K, Lesne S. on NEWS: The Toxic Fold? Aβ Dodecamers, Tetramers Show Their Conformations, Two New Articles Use Synthetic Aβ to Study Oligomerization
The first article... 23 Jun 2009.
|
|
|
|
|
|
Ashe K. on NEWS: Place Cells: New Way to Probe Spatial Memory in AD Mice, The electrophysiological findings in this interesting paper appear solid. However, the... 27 May 2008.
|
|
|
|
|
|
Ashe K, Lesne S. on PAPER: Nimmrich V. et al., 2008, Aβ1-42 globulomers (1) are synthetic soluble Aβ42 oligomers, which are interesting entities... 1 Feb 2008.
|
|
|
|
|
|
Ashe K. on PAPER: Marchesi VT. et al., 2005, Dr. Marchesi proposes that the accumulation of Aβ dimers in lipid rafts may disturb the normal... 1 Nov 2005.
|
|
|
|
|
|
Ashe K. on LIVE DISCUSSION: Messing with the Membrane—An Alternative Interpretation of the Amyloid-β Hypothesis, Dr. Marchesi proposes that the accumulation of Aβ dimers in lipid rafts may disturb the normal... 1 Nov 2005.
|
|
|
|
|
|
Ashe K. on NEWS: Tackling Alzheimer’s from the Outside in, These are a series of beautifully done studies, which strongly support the Aβ cascade... 5 Aug 2004.
|
|
|
|
|
|
Ashe K. on NEWS: Alzheimer’s Vaccine: In Some Patients, at Least, It Might Just Work, This paper shows that immunization with Aβ may slow the progression of Alzheimer’s disease, but... 23 May 2003.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
